Let us be the generation that stands up to cytomegalovirus (CMV), a highly contagious viral infection that can harm an unborn child. Learn more about a research study for a potential vaccine and how you can join.
What is CMV?
CMV is a common virus that is often overlooked because healthy people who get it rarely show symptoms. But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases.
Is treatment available?
There are currently no approved vaccines or treatments available to prevent CMV. That is why it is so important that we work together to make sure investigational vaccines are safe and effective.
What is the CMVictory Trial?
The goal of this clinical trial is to evaluate the efficacy and safety of an investigational vaccine called mRNA-1647 against CMV infection.
CMV is the number one infection that causes birth defects in the U.S. and one of the most common infectious causes of birth defects globally.
Who can join this clinical trial?
This trial is looking for volunteers. To join this trial, you must be:
✓ A woman between 16-40 years of age
✓ In good health In close contact with at least one child 5 years of age or younger for at least 8 hours a week, if age 20 or older
✓ Not pregnant or planning on becoming pregnant within the next 9 months
Diseases do not discriminate and neither should clinical trials Moderna is committed to researching safe and effective mRNA-based vaccines and therapies to bring better health and living to people of all ages, sexes, and backgrounds.
The study doctor will discuss additional participation requirements with you and can answer any questions you may have during the trial.
Interested? Contact the clinical research site listed below:
Indago Research and Health Center Inc.